Immunotherapy of Hodgkin’s lymphoma: a new treatment strategy
Summary. This literature review highlights a new approach to the treatment of relapses and refractory Hodgkin’s lymphoma with application of immunotherapy. The data of clinical trials regarding effectiveness and safety profile of inhibitors of control immune points nivolumab and pembrolizumab and their combinations are presented here.
Leave a comment